Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation associated with KIF11 pathogenic variant: case report and genotype-phenotype correlation analysis. | BMC Ophthalmol | 2025 | 40739497 | PubTator, text mining | PubMed |
| Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection. | Nat Microbiol | 2025 | 40739040 | PubTator, text mining | PubMed |
| Dynamics of neutralizing antibodies against COVID-19 Omicron subvariants following breakthrough infection in southwest China between December 2022 and April 2024. | Signal Transduct Target Ther | 2025 | 40738879 | PubTator, text mining | PubMed |
| 19S proteasome loss regulates mitotic spindle assembly through a ubiquitin-independent degradation mechanism. | Cell Rep | 2025 | 40705606 | PubTator, text mining | PubMed |
| Molecular Guardians of Oocyte Maturation: A Systematic Review on TUBB8, KIF11, and CKAP5 in IVF Outcomes. | Int J Mol Sci | 2025 | 40650169 | PubTator, text mining | PubMed |
| Conformational Dynamics and Binding Interactions of SARS-CoV-2 Spike Protein Variants: Omicron, XBB.1.9.2, and EG.5. | J Chem Inf Model | 2025 | 40643983 | PubTator, text mining | PubMed |
| Lessons Learned from a Ligand-Unbinding Stress Test for Weighted Ensemble Simulations. | ACS Omega | 2025 | 40620993 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis. | Leuk Res | 2025 | 40591982 | PubTator, text mining | PubMed |
| De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning. | Comput Biol Med | 2025 | 40578154 | PubTator, text mining | PubMed |
| From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions. | Chem Rev | 2025 | 40553022 | PubTator, text mining | PubMed |
| Network-based analysis of candidate oncogenes and pathways in hepatocellular carcinoma. | Biochem Biophys Rep | 2025 | 40546347 | PubTator, text mining | PubMed |
| Antitumor Activity of Tetrahydro-β-carboline Derivatives via Inhibition of Kinesin Spindle Protein: Validation by Molecular Docking, Molecular Dynamics, and In Vitro Assays. | Int J Mol Sci | 2025 | 40508205 | PubTator, text mining | PubMed |
| Gene expression network analysis identified CDK1 and KIF11 as possible key molecules in the development of colorectal cancer from normal tissues. | Genomics Inform | 2025 | 40457491 | PubTator, text mining | PubMed |
| C/EBPβ increases tumor aggressiveness by enhancing KIFC1 expression in androgen receptor negative triple negative breast cancer. | Cell Commun Signal | 2025 | 40448099 | PubTator, text mining | PubMed |
| Novel KIF11 Mutation Associated with Microcephaly, Chorioretinopathy and Impaired Intellectual Development: 20 Years of Follow-Up. | Children (Basel) | 2025 | 40426739 | PubTator, text mining | PubMed |
| The Quest for Ligands Against Kinesin Motor Protein Eg5. | Arch Pharm (Weinheim) | 2025 | 40405485 | PubTator, text mining | PubMed |
| Structure-guided development of Quinoline derivatives targeting kinesin spindle protein. | Bioorg Med Chem Lett | 2025 | 40381704 | PubTator, text mining | PubMed |
| A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. | Int J Biol Macromol | 2025 | 40306500 | PubTator, text mining | PubMed |
| TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma. | Front Biosci (Landmark Ed) | 2025 | 40302342 | PubTator, text mining | PubMed |
| Population immunity enhances the evolution of SARS-CoV-2 in Beijing revealed by wastewater genomic surveillance. | Water Res | 2025 | 40245799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=8